Abstract:
본 발명은 재조합 인플루엔자 A 바이러스, 이의 제조방법 및 이를 포함하는 clade 2.3.4.4B에 속하는 H5 혈청형 인플루엔자 A 바이러스에 대한 백신 조성물을 제공한다. 본 발명은 고병원성 조류 인플루엔자 바이러스에 방어효과를 나타내는 유전자 재조합 백신을 제조함으로써, 해외로부터 유입되거나 국내에서 발생하는 H5 혈청형 고병원성 조류 인플루엔자 발생에 대비한 방어효과를 통해 질병 방제에 기여할 수 있다. 또한, 상기 백신 조성물은 HA 분절 부위의 고병원성 유전자가 제거되어 병원성이 약하고 안전성이 우수할 뿐만 아니라, 종란(egg) 내 증식성 및 닭에서의 방어능이 우수하다.
Abstract:
A manufacturing method of extract of codonopsis lanceolata is provided to increase immunomodulation enhancement of pathogenic bacteria, to be useful as immunostimulator preventing and treating efficiently disease of the animal, an adjuvant improving effect of vaccine and an adjuvant treatment making therapeutic efficacy reinforced. A manufacturing method of extract of codonopsis lanceolata comprises steps of: obtaining the first extracts and residue by heating powder of leaf and stem of the dried Condonopsis lanceolata Trautv into distilled water, separating the first extracts separately, putting it into residue, heating it obtaining the second extraction extracts; mixing the first extracts of the obtained Condonopsis lanceolata Trautv stem and leaf and the second extracts of Condonopsis lanceolata Trautv stem and leaf, putting ethanol into the mixing extract, obtaining precipitated polysaccharide by stationing the obtained solution and centrifuging the precipitated polysaccharide; and center-rinsing the separated polysaccharide to the ethanol, drying the washed material, dissolving dried material with distilled water, filtering the obtained solution and obtaining undiluted solution.
Abstract:
A manufacturing method of Scolopendra subspinipes extract making immunogenicity of animal is provided to be useful as immunostimulator preventing and treating efficiently disease of the animal, an adjuvant improving effect of vaccine and an adjuvant treatment making therapeutic efficacy reinforced. A manufacturing method of Scolopendra subspinipes extract making immunogenicity of animal comprises steps of: put the Scolopendra subspinipes powder into distilled water; obtaining extract by heating obtained solution, filtering obtained extract using filter paper firstly, filtering filtered material using filter paper secondly and sterilizing filtered material.
Abstract:
An immunostimulant containing the lystic extract of Candida sake is provided to increase activity of neutrophil and lymphocyte as major immune cells of animals, thereby protecting animals from diseases. The immunostimulant contains the lystic extract of Candida sake which is prepared by cultivating Candida sake in yeast malt extract agar broth at 30 deg. C for 72 hours, centrifuging the cultured fluid at 3000Xg for 30 minutes and collecting it, rinsing the collected pellet with phosphate buffered saline(PBS) of pH 7.2 and suspending the rinsed pellet in PBS, adding 5% of TNT solution containing 50mM of Tris-HCl, 0.15M of NaCl and 4% Triton x-114 as solubilizing agent into the Candida sake suspension, stirring the mixture at room temperature for 2-3 days to solubilize the Streptomyces albus, and regulating pH of the solution to 6.5-7.2, and drying the solution in the thermostatic chamber.
Abstract translation:提供含有念珠菌精液提取物的免疫刺激剂,以增加嗜中性粒细胞和淋巴细胞作为动物主要免疫细胞的活性,从而保护动物免受疾病。 免疫刺激剂含有通过在30℃下在酵母麦芽提取物琼脂培养液中培育念珠菌精油而制备的念珠菌清酒。 培养72小时,将培养液以3000Xg离心30分钟并收集,用pH7.2的磷酸盐缓冲盐水(PBS)冲洗收集的沉淀物,并将漂洗的沉淀悬浮于PBS中,加入5%含有50mM Tris -HCl,0.15M NaCl和4%Triton x-114作为增溶剂加入到念珠菌悬浮液中,在室温下搅拌混合物2-3天以溶解链霉菌,并将溶液的pH调节至6.5-7.2 ,并干燥恒温室中的溶液。
Abstract:
Glycine max (L.) Merrill lectin is provided to reinforce immunogenicity of animals, to improve effect of an immunoadjuvant and a vaccine preventing and treating disease of the animals efficiently and to increase defence ability aspecific to attack inoculation of pathogenic bacteria. An immunoadjuvant comprises Glycine max (L.) Merrill lectin as an active ingredient. Additionally, the Glycine max (L.) Merrill lectin is used for a vaccine throne and an adjuvant treatment as the active ingredient.
Abstract:
본 발명은 동물의 면역능을 증강시키는 더덕 추출물 및 그 제조방법과 용도에 관한 것이다. 보다 상세하게는 더덕줄기 및 잎을 음지에서 건조시켜 마쇄하여 열탕용 봉지에 넣고 증류수 중에 가열하여 1차 추출한 후, 추출물은 별도로 분리하고 잔류물에 재차 증류수를 넣고 열탕하여 2차 추출하여 추출물을 얻는 단계와, 1차 및 2차 추출물을 혼합하여 추출물에 2배량의 에탄올을 가하여 4∼6℃ 냉장실에서 24시간 정치시켜 침전된 다당체를 원심분리하는 단계와, 분리된 다당체를 순수 에탄올로 원심 세척한 후 35∼38℃ 항온실에서 건조하여 증류수로 1mg/ml 농도로 용해시켜 세균여과지로 여과하여 원액을 얻는 단계로 구성된다. 본 발명의 더덕추출물은 동물의 주요 면역세포인 호중구의 각종 활성과 싸이토카인 생성을 증강시키고 병원성세균의 공격접종에 대한 비특이적인 방어능을 증진시키는 효과가 있으므로 동물용 의약품으로써 면역증강제. 백신보좌제 첨가물 그리고 보조치료제 등으로 광범위하게 활용될 수 있을 것이다.